FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jay Levy

Research Profile

Living Beings

Physiology

Virus Replication

Disorders

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Shweta Kaushik; Mira Patel; Barbara Schmidt; Fernando Teque; Sue H Fujimura; Jay A Levy
Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.
Michael Scott Killian; Jay A Levy
HIV/AIDS: 30 years of progress and future challenges.
Jay A Levy
Virus-host interactions in HIV pathogenesis: directions for therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jay Levy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shweta Kaushik; Mira Patel; Barbara Schmidt; Fernando Teque; Sue H Fujimura; Jay A Levy
Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.
AIDS research and human retroviruses 2013;29(3):501-10.
2011: Michael Scott Killian; Jay A Levy
HIV/AIDS: 30 years of progress and future challenges.
European journal of immunology 2011;41(12):3401-11.
2011: Jay A Levy
Virus-host interactions in HIV pathogenesis: directions for therapy.
Advances in dental research 2011;23(1):13-8.
2011: Michael Scott Killian; Carl Johnson; Fernando Teque; Sue Fujimura; Jay A Levy
Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.
Journal of virology 2011;85(4):1696-705.
2011: Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner Greene; Jay A Levy; Joel Palefsky
HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.
Virology 2011;409(2):211-22.
2009: Michael Scott Killian; Jeremy Roop; Sharon Ng; Frederick Hecht; Jay A Levy
CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.
Journal of clinical immunology 2009;29(3):311-8.
2009: Jason D Barbour; Lishomwa C Ndhlovu; Qi Xuan Tan; Terence Ho; Lorrie Epling; Barry M Bredt; Jay A Levy; Frederick Hecht; Elizabeth Sinclair
High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication.
PloS one 2009;4(2):e4408.
2008: Kyle R Bonneau; Sharon Ng; Hillary Foster; Kelly B Choi; Ben Berkhout; Arnold Rabson; Carl E Mackewicz; Jay A Levy
Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
Virology 2008;373(1):30-8.
2007: Beatriz Martinez-Mariño; Hillary Foster; Yanling Hao; Jay A Levy
Differential gene expression in CD8(+) cells from HIV-1-infected subjects showing suppression of HIV replication.
Virology 2007;362(1):217-25.
2006: Michael Scott Killian; Philip J Norris; Bhupat D Rawal; Mila Lebedeva; Frederick Hecht; Jay A Levy; Michael P Busch
The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response.
AIDS research and human retroviruses 2006;22(7):640-7.
2006: Michael Scott Killian; Sue Fujimura; Frederick Hecht; Jay A Levy
Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
AIDS (London, England) 2006;20(9):1247-52.
2006: C Bradley Hare; Brandee L Pappalardo; Michael P Busch; Annika C Karlsson; Bruce Phelps; Steven S Alexander; Christopher Bentsen; Clarissa A Ramstead; Douglas F Nixon; Jay A Levy; Frederick Hecht
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(5):700-8.
2006: Jay A Levy
HIV pathogenesis: knowledge gained after two decades of research.
Advances in dental research 2006;19(1):10-6.
2006: Barbara Schmidt; Sue Fujimura; Jeffrey N Martin; Jay A Levy
Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy.
Journal of clinical immunology 2006;26(1):55-64.
2005: Barbara Schmidt; Brittany M Ashlock; Hillary Foster; Sue Fujimura; Jay A Levy
HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.
Virology 2005;343(2):256-66.
2005: Michael Scott Killian; Sharon Ng; Carl E Mackewicz; Jay A Levy
A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses.
Journal of immunological methods 2005;304(1-2):137-50.
2005: Christopher P Locher; Stephanie A Witt; Rachel Kassel; Noah L Dowell; Sue Fujimura; Jay A Levy
Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
The Journal of general virology 2005;86(Pt 4):1171-9.
2005: Leyla S Diaz; Hillary Foster; Mars R Stone; Sue Fujimura; David A Relman; Jay A Levy
VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(3):1574-9.
2004: Barbara Schmidt; Iain Scott; Robert G Whitmore; Hillary Foster; Sue Fujimura; Jürgen Schmitz; Jay A Levy
Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation.
Virology 2004;329(2):280-8.
2004: Beatriz Martinez-Mariño; Stephen Shiboski; Frederick Hecht; James O Kahn; Jay A Levy
Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.
AIDS (London, England) 2004;18(15):1991-9.
2004: Barbara Schmidt; Brittany Ashlock; Frank Neipel; Jay A Levy
Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production.
Journal of clinical microbiology 2004;42(9):4300-2.
2004: Christopher P Locher; Stephanie A Witt; Brittany M Ashlock; Patricia Polacino; Shiu-Lok Hu; Stephen Shiboski; Ann M Schmidt; Michael B Agy; David M Anderson; Silvija I Staprans; Jan zur Megede; Jay A Levy
Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.
Vaccine 2004;22(17-18):2261-72.
2004: JoAnn Castelli; Elaine K Thomas; Michel Gilliet; Yong-Jun Liu; Jay A Levy
Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL-15.
Blood 2004;103(7):2699-704.
2004: Beatriz Martinez-Mariño; Brittany M Ashlock; Stephen Shiboski; Frederick Hecht; Jay A Levy
Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection.
Journal of clinical immunology 2004;24(2):135-44.
2004: Christopher P Locher; Stephanie A Witt; Brittany M Ashlock; Jay A Levy
Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine.
DNA and cell biology 2004;23(2):107-10.
2003: Christopher P Locher; David Putnam; Robert Langer; Stephanie A Witt; Brittany M Ashlock; Jay A Levy
Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation.
Immunology letters 2003;90(2-3):67-70.
2003: Jay A Levy
The search for the CD8+ cell anti-HIV factor (CAF).
Trends in immunology 2003;24(12):628-32.
2003: Jonathan Z Li; Elizabeth C Mack; Jay A Levy
Virucidal efficacy of soap and water against human immunodeficiency virus in genital secretions.
Antimicrobial agents and chemotherapy 2003;47(10):3321-2.
2003: Carl E Mackewicz; Jun Yuan; Patti Tran; Leyla Diaz; Elizabeth Mack; Michael Selsted; Jay A Levy
alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors.
AIDS (London, England) 2003;17(14):F23-32.
2003: Jay A Levy; Iain Scott; Carl E Mackewicz
Protection from HIV/AIDS: the importance of innate immunity.
Clinical immunology (Orlando, Fla.) 2003;108(3):167-74.
2003: Leyla S Diaz; Mars R Stone; Carl E Mackewicz; Jay A Levy
Differential gene expression in CD8+ cells exhibiting noncytotoxic anti-HIV activity.
Virology 2003;311(2):400-9.
2003: Carl E Mackewicz; Baikun Wang; Sunil S Metkar; Matthew Richey; Christopher J Froelich; Jay A Levy
Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules.
Blood 2003;102(1):180-3.
2003: Carl E Mackewicz; Charles S Craik; Jay A Levy
The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(6):3433-8.
2003: Jay A Levy
Is HIV superinfection worrisome?
Lancet 2003;361(9352):98-9.
2003: Christopher P Locher; Sue Fujimura; Krishna K Murthy; Kathleen M Brasky; Michelle Leland; Jay A Levy
Expression patterns of phenotypic markers on lymphocytes from human immunodeficiency virus type 2-infected baboons.
AIDS research and human retroviruses 2003;19(1):31-40.
2003: Christopher P Locher; Stephanie A Witt; Brian G Herndier; Nancy W Abbey; Klara Tenner-Racz; Paul Racz; Nancy B Kiviat; Krishna K Murthy; Kathleen M Brasky; Michelle Leland; Jay A Levy
Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons.
Journal of virology 2003;77(1):77-83.
2002: Christopher P Locher; Stephanie A Witt; Brittany M Ashlock; Jay A Levy
Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element.
DNA and cell biology 2002;21(8):581-6.
2002: Jay A Levy
HIV-1: hitching a ride on erythrocytes.
Lancet 2002;359(9325):2212-3.
2002: JoAnn C Castelli; Steven G Deeks; Stephen Shiboski; Jay A Levy
Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals.
Blood 2002;99(11):4225-7.
2001: Christopher P Locher; Stephanie A Witt; Jay A Levy
The nuclear factor kappa B and Spl binding sites do not appear to be involved in virus suppression by CD8 T lymphocytes.
AIDS (London, England) 2001;15(18):2455-7.
2001: Christopher P Locher; Stephanie A Witt; Brian G Herndier; Klara Tenner-Racz; Paul Racz; Jay A Levy
Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.
Immunological reviews 2001;183():127-40.
2001: Smita A Ghanekar; SA Stranford; J C Ong; Joshua M Walker; Vernon C Maino; Jay A Levy
Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy.
AIDS (London, England) 2001;15(14):1885-7.
2001: Jay A Levy
What can be achieved with an HIV vaccine?
Lancet 2001;357(9251):223-4.
2001: SA Stranford; J C Ong; B Martinez-Marino; M Busch; Frederick Hecht; J Kahn; Jay A Levy
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(2):597-602.
2000: S Kliks; Christopher H Contag; H Corliss; Gerald Learn; A Rodrigo; Diane Wara; J I Mullins; Jay A Levy
Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns.
AIDS research and human retroviruses 2000;16(13):1223-33.
2000: DJ Blackbourn; ET Lennette; Barbara Klencke; Ashlee V Moses; bala chandran; M Weinstein; Richard G Glogau; Marlys H Witte; DL Way; T Kutzkey; Brian G Herndier; Jay A Levy
The restricted cellular host range of human herpesvirus 8.
AIDS (London, England) 2000;14(9):1123-33.
2000: Carl E Mackewicz; Bruce K Patterson; S A Lee; Jay A Levy
CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration.
The Journal of general virology 2000;81(Pt 5):1261-4.
2000: Carl E Mackewicz; J Lieberman; Christopher J Froelich; Jay A Levy
HIV virions and HIV infection in vitro are unaffected by human granzymes A and B.
AIDS research and human retroviruses 2000;16(4):367-72.
2000: DJ Blackbourn; S Fujimura; T Kutzkey; Jay A Levy
Induction of human herpesvirus-8 gene expression by recombinant interferon gamma.
AIDS (London, England) 2000;14(1):98-9.
1999: Christopher P Locher; Robert M Grant; Eric Collisson; G Reyes-Terán; Tarek Elbeik; James O Kahn; Jay A Levy
Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination.
AIDS research and human retroviruses 1999;15(18):1685-9.
1999: DV Mourich; S Lee; G Reyes-Teran; Carl E Mackewicz; Jay A Levy
Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease.
AIDS research and human retroviruses 1999;15(17):1573-5.
1999: E Barker; KN Bossart; Sue Fujimura; Jay A Levy
The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication.
Cellular immunology 1999;196(2):95-103.
1999: G Greco; Carl E Mackewicz; Jay A Levy
Sensitivity of human immunodeficiency virus infection to various alpha, beta and gamma chemokines.
The Journal of general virology 1999;80 ( Pt 9)():2369-73.
1999: Christopher P Locher; DJ Blackbourn; Jay A Levy
Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboons.
Immunology letters 1999;66(1-3):151-7.
1999: SA Stranford; Joan Skurnick; Donald B Louria; D Osmond; S Y Chang; J Sninsky; G Ferrari; K Weinhold; C Lindquist; Jay A Levy
Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(3):1030-5.
1999: Jay A Levy
Xenotropism: the elusive viral receptor finally uncovered.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(3):802-4.
1999: G Greco; Sue Fujimura; DV Mourich; Jay A Levy
Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.
Journal of virology 1999;73(2):1528-34.
1999: DJ Blackbourn; Dennis H Osmond; Jay A Levy; ET Lennette
Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners.
The Journal of infectious diseases 1999;179(1):237-9.
1998: E Barker; KN Bossart; Jay A Levy
Differential effects of CD28 costimulation on HIV production by CD4+ cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(11):6223-7.
1998: Carl E Mackewicz; MR Garovoy; Jay A Levy
HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication.
Journal of virology 1998;72(12):10165-70.
1998: G Greco; E Barker; Jay A Levy
Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production.
AIDS research and human retroviruses 1998;14(16):1407-11.
1998: E Barker; Carl E Mackewicz; G Reyes-Terán; A Sato; SA Stranford; Sue Fujimura; Cindy Christopherson; S Y Chang; Jay A Levy
Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome.
Blood 1998;92(9):3105-14.
1998: Christopher P Locher; Susan W Barnett; Brian G Herndier; DJ Blackbourn; G Reyes-Terán; Krishna K Murthy; Kathleen M Brasky; G B Hubbard; Todd A Reinhart; Ashley T Haase; Jay A Levy
Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans.
Archives of pathology & laboratory medicine 1998;122(6):523-33.
1998: E Barker; KN Bossart; Jay A Levy
Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1725-9.
1998: Jay A Levy; F Hsueh; DJ Blackbourn; Diane Wara; Peggy Sue Weintrub
CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children.
The Journal of infectious diseases 1998;177(2):470-2.
1998: Christopher P Locher; DJ Blackbourn; Brian G Herndier; G Reyes-Terán; Susan W Barnett; Krishna K Murthy; Jay A Levy
Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons.
AIDS research and human retroviruses 1998;14(1):79-82.
1998: DJ Blackbourn; ET Lennette; J Ambroziak; DV Mourich; Jay A Levy
Human herpesvirus 8 detection in nasal secretions and saliva.
The Journal of infectious diseases 1998;177(1):213-6.
1997: E Barker; KN Bossart; Sue Fujimura; Jay A Levy
CD28 costimulation increases CD8+ cell suppression of HIV replication.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):5123-31.
1997: Christopher P Locher; DJ Blackbourn; Susan W Barnett; Krishna K Murthy; Elaine K Cobb; Scott Rouse; G Greco; G Reyes-Terán; Kathleen M Brasky; Kenneth D Carey; Jay A Levy
Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response.
The Journal of infectious diseases 1997;176(4):948-59.
1997: Carl E Mackewicz; E Barker; G Greco; G Reyes-Teran; Jay A Levy
Do beta-chemokines have clinical relevance in HIV infection?
The Journal of clinical investigation 1997;100(4):921-30.
1997: DJ Blackbourn; Christopher P Locher; B Ramachandran; Susan W Barnett; Krishna K Murthy; Kenneth D Carey; Kathleen M Brasky; Jay A Levy
CD8+ cells from HIV-2-infected baboons control HIV replication.
AIDS (London, England) 1997;11(6):737-46.
1997: Carl E Mackewicz; R Orque; J Jung; Jay A Levy
Derivation of herpesvirus saimiri-transformed CD8+ T cell lines with noncytotoxic anti-HIV activity.
Clinical immunology and immunopathology 1997;82(3):274-81.
1997: DJ Blackbourn; J Ambroziak; ET Lennette; M Adams; B Ramachandran; Jay A Levy
Infectious human herpesvirus 8 in a healthy North American blood donor.
Lancet 1997;349(9052):609-11.
1997: Jay A Levy
Three new human herpesviruses (HHV6, 7, and 8).
Lancet 1997;349(9051):558-63.
1996: E Barker; KN Bossart; Christopher P Locher; B K Patterson; Jay A Levy
CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.
The Journal of general virology 1996;77 ( Pt 12)():2953-62.
1996: Carl E Mackewicz; E Barker; Jay A Levy
Role of beta-chemokines in suppressing HIV replication.
Science (New York, N.Y.) 1996;274(5291):1393-5.
1996: DJ Blackbourn; Carl E Mackewicz; E Barker; T K Hunt; Brian G Herndier; Ashley T Haase; Jay A Levy
Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(23):13125-30.
1996: Christopher P Locher; DJ Blackbourn; B A Castro; Kathleen M Brasky; Jay A Levy
Susceptibility of peripheral blood mononuclear cells from gorillas, orangutans and baboons to diverse HIV isolates.
AIDS (London, England) 1996;10(12):1438-40.
1996: Krishna K Murthy; E K Cobb; Z el-Amad; H Ortega; F C Hsueh; William C Satterfield; D R Lee; M L Kalish; Nancy Haigwood; R C Kennedy; K S Steimer; A Schultz; Jay A Levy
Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees.
AIDS research and human retroviruses 1996;12(14):1341-8.
1996: Susan W Barnett; Harold Legg; Y Sun; J Klinger; DJ Blackbourn; Christopher P Locher; Jay A Levy
Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2.
Virology 1996;222(1):257-61.
1996: Jay A Levy
Surrogate markers in AIDS research. Is there truth in numbers?
JAMA : the journal of the American Medical Association 1996;276(2):161-2.
1996: Jay A Levy
The value of primate models for studying human immunodeficiency virus pathogenesis.
Journal of medical primatology 1996;25(3):163-74.
1996: Jay A Levy; Carl E Mackewicz; E Barker
Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells.
Immunology today 1996;17(5):217-24.
1995: Z el-Amad; Krishna K Murthy; K Higgins; E K Cobb; Nancy Haigwood; Jay A Levy; K S Steimer
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.
AIDS (London, England) 1995;9(12):1313-22.
1995: E Barker; Carl E Mackewicz; Jay A Levy
Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(24):11135-9.
1995: Jay A Levy
A new human herpesvirus: KSHV or HHV8?
Lancet 1995;346(8978):786.
1995: S Tang; B Patterson; Jay A Levy
Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation.
Journal of virology 1995;69(9):5659-65.
1995: H Ichimura; Jay A Levy
Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Virology 1995;211(2):554-60.
1995: Jonathan S Allan; P Ray; SR Broussard; E Whitehead; G Hubbard; T Butler; Kathleen M Brasky; Paul A Luciw; C Cheng-Mayer; Jay A Levy
Infection of baboons with simian/human immunodeficiency viruses.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;9(5):429-41.
1995: Paul A Luciw; E Pratt-Lowe; Karen E S Shaw; Jay A Levy; Cecilia Cheng-Mayer
Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
Proceedings of the National Academy of Sciences of the United States of America 1995;92(16):7490-4.
1995: Earl T Sawai; A S Baur; B Matija Peterlin; Jay A Levy; Cecilia Cheng-Mayer
A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity.
The Journal of biological chemistry 1995;270(25):15307-14.
1995: J A Ambroziak; DJ Blackbourn; Brian G Herndier; R G Glogau; J H Gullett; A R McDonald; ET Lennette; Jay A Levy
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.
Science (New York, N.Y.) 1995;268(5210):582-3.
1995: Carl E Mackewicz; DJ Blackbourn; Jay A Levy
CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(6):2308-12.
1994: Carl E Mackewicz; L C Yang; Jeffrey D Lifson; Jay A Levy
Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection.
Lancet 1994;344(8938):1671-3.
1994: F W Hsueh; C M Walker; DJ Blackbourn; Jay A Levy
Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
Cellular immunology 1994;159(2):271-9.
1994: Susan W Barnett; Krishna K Murthy; Brian G Herndier; Jay A Levy
An AIDS-like condition induced in baboons by HIV-2.
Science (New York, N.Y.) 1994;266(5185):642-6.
1994: Jay A Levy
Long-term survivors of HIV infection.
Hospital practice (Office ed.) 1994;29(10):41-4, 47, 51-2.
1994: DJ Blackbourn; Carl E Mackewicz; E Barker; Jay A Levy
Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine.
Research in immunology 1994;145(8-9):653-8; discussion 658-9.
1994: S C Kliks; D W Wara; D V Landers; Jay A Levy
Features of HIV-1 that could influence maternal-child transmission.
JAMA : the journal of the American Medical Association 1994;272(6):467-74.
1994: A Koito; G Harrowe; Jay A Levy; Cecilia Cheng-Mayer
Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
Journal of virology 1994;68(4):2253-9.
1994: H Ichimura; S C Kliks; S Visrutaratna; C Y Ou; Marcia L Kalish; Jay A Levy
Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand.
AIDS research and human retroviruses 1994;10(3):263-9.
1994: Earl T Sawai; A Baur; H Struble; B Matija Peterlin; Jay A Levy; Cecilia Cheng-Mayer
Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(4):1539-43.
1994: O Dumitrescu; Marcia L Kalish; S C Kliks; Claudiu Bandea; Jay A Levy
Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype.
The Journal of infectious diseases 1994;169(2):281-8.
1994: Carl E Mackewicz; H Ortega; Jay A Levy
Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor.
Cellular immunology 1994;153(2):329-43.
1994: E Barker; S F Fujimura; M B Fadem; A L Landay; Jay A Levy
Immunologic abnormalities associated with chronic fatigue syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18 Suppl 1():S136-41.
1994: Jay A Levy
Viral studies of chronic fatigue syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18 Suppl 1():S117-20.
1994: A M Eaton; Kenneth Ugen; D B Weiner; T Wildes; Jay A Levy
An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement.
AIDS research and human retroviruses 1994;10(1):13-8.
1993: S C Kliks; T Shioda; Nancy Haigwood; Jay A Levy
V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(24):11518-22.
1993: M LeGuern; T Shioda; Jay A Levy; Cecilia Cheng-Mayer
Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates.
Virology 1993;195(2):441-7.
1993: A Werner; Jay A Levy
Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4.
Journal of virology 1993;67(5):2566-74.
1993: Jay A Levy
Pathogenesis of human immunodeficiency virus infection.
Microbiological reviews 1993;57(1):183-289.
1993: Susan W Barnett; M Quiroga; A Werner; D Dina; Jay A Levy
Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain.
Journal of virology 1993;67(2):1006-14.
1993: L Z Pan; A Werner; Jay A Levy
Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages.
Journal of clinical microbiology 1993;31(2):283-8.
1993: Jay A Levy
HIV and host immune responses in AIDS pathogenesis.
Journal of clinical apheresis 1993;8(1):19-28.
1992: A Barboza; B A Castro; M Whalen; C C Moore; J S Parkin; W L Miller; F Gonzalez-Scarano; Jay A Levy
Infection of cultured human adrenal cells by different strains of HIV.
AIDS (London, England) 1992;6(12):1437-43.
1992: B A Castro; J Homsy; E Lennette; Krishna K Murthy; J W Eichberg; Jay A Levy
HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection.
Clinical immunology and immunopathology 1992;65(3):227-33.
1992: T Shioda; Jay A Levy; Cecilia Cheng-Mayer
Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(20):9434-8.
1992: L Poulin; Jay A Levy
The HIV-1 nef gene product is associated with phosphorylation of a 46 kD cellular protein.
AIDS (London, England) 1992;6(8):787-91.
1992: Carl E Mackewicz; Jay A Levy
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
AIDS research and human retroviruses 1992;8(6):1039-50.
1992: S Tang; L Poulin; Jay A Levy
Lack of human immunodeficiency virus type 1 (HIV-1) replication and accumulation of viral DNA in HIV-1-infected T cells blocked in cell replication.
The Journal of general virology 1992;73 ( Pt 4)():933-9.
1992: M Le Guern; Jay A Levy
Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):363-7.
1991: Cecilia Cheng-Mayer; T Shioda; Jay A Levy
Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
Journal of virology 1991;65(12):6931-41.
1991: L Z Pan; Haynes W Sheppard; W Winkelstein; Jay A Levy
Lack of detection of human immunodeficiency virus in persistently seronegative homosexual men with high or medium risks for infection.
The Journal of infectious diseases 1991;164(5):962-4.
1991: C M Walker; G A Thomson-Honnebier; F C Hsueh; A L Erickson; L Z Pan; Jay A Levy
CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses.
Cellular immunology 1991;137(2):420-8.
1991: L Poulin; L A Evans; S B Tang; A Barboza; H Legg; Dan R Littman; Jay A Levy
Several CD4 domains can play a role in human immunodeficiency virus infection in cells.
Journal of virology 1991;65(9):4893-901.
1991: B A Castro; M Nepomuceno; Nicholas W Lerche; J W Eichberg; Jay A Levy
Persistent infection of baboons and rhesus monkeys with different strains of HIV-2.
Virology 1991;184(1):219-26.
1991: P S Weintrub; P P Ulrich; J R Edwards; F Boucher; Jay A Levy; M J Cowan; Girish Vyas
Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women.
AIDS (London, England) 1991;5(7):881-4.
1991: S B Tang; Jay A Levy
Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells.
Journal of virological methods 1991;33(1-2):39-46.
1991: Carl E Mackewicz; H W Ortega; Jay A Levy
CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.
The Journal of clinical investigation 1991;87(4):1462-6.
1991: Cecilia Cheng-Mayer; D Seto; Jay A Levy
Altered host range of HIV-1 after passage through various human cell types.
Virology 1991;181(1):288-94.
1991: N L Martin; Jay A Levy; H Legg; P S Weintrub; M J Cowan; D W Wara
Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins.
The Journal of pediatrics 1991;118(3):354-8.
1991: T Shioda; Jay A Levy; Cecilia Cheng-Mayer
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
Nature 1991;349(6305):167-9.
1991: M Brown; S Reed; Jay A Levy; M Busch; James H McKerrow
Detection of HIV-1 in Entamoeba histolytica without evidence of transmission to human cells.
AIDS (London, England) 1991;5(1):93-6.
1991: Jay A Levy
Viral and cellular factors influencing HIV tropism.
Advances in experimental medicine and biology 1991;300():1-15.
1991: B A Castro; C M Walker; J W Eichberg; Jay A Levy
Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees.
Cellular immunology 1991;132(1):246-55.
1990: Jay A Levy
The pathogenesis of HIV infection.
Hospital practice (Office ed.) 1990;25(11):41-8.
1990: C D Weiss; Jay A Levy; J M White
Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles.
Journal of virology 1990;64(11):5674-7.
1990: Jay A Levy; A Landay; ET Lennette
Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture.
Journal of clinical microbiology 1990;28(10):2362-4.
1990: M Canivet; A D Hoffman; D Hardy; J Sernatinger; Jay A Levy
Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses.
Virology 1990;178(2):543-51.
1990: B A Castro; Susan W Barnett; L A Evans; J Moreau; K Odehouri; Jay A Levy
Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains.
Virology 1990;178(2):527-34.
1990: Cecilia Cheng-Mayer; M Quiroga; J W Tung; D Dina; Jay A Levy
Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation.
Journal of virology 1990;64(9):4390-8.
1990: Jay A Levy; F Ferro; ET Lennette; L Oshiro; L Poulin
Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual.
Virology 1990;178(1):113-21.
1990: L D Wiviott; C M Walker; Jay A Levy
CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture.
Cellular immunology 1990;128(2):628-34.
1990: Jay A Levy; F Ferro; Deborah Greenspan; ET Lennette
Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.
Lancet 1990;335(8697):1047-50.
1990: S B Tang; Jay A Levy
Parameters involved in the cell fusion induced by HIV.
AIDS (London, England) 1990;4(5):409-15.
1990: J Homsy; M Meyer; Jay A Levy
Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.
Journal of virology 1990;64(4):1437-40.
1990: W H Yong; S Wyman; Jay A Levy
Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction.
AIDS (London, England) 1990;4(3):199-206.
1989: L A Evans; Jay A Levy
Characteristics of HIV infection and pathogenesis.
Biochimica et biophysica acta 1989;989(3):237-54.
1989: Cecilia Cheng-Mayer; P Iannello; K Shaw; Paul A Luciw; Jay A Levy
Differential effects of nef on HIV replication: implications for viral pathogenesis in the host.
Science (New York, N.Y.) 1989;246(4937):1629-32.
1989: M Schiødt; Deborah Greenspan; Jay A Levy; Jay A Nelson; David Chernoff; H Hollander; John Greenspan
Does HIV cause salivary gland disease?
AIDS (London, England) 1989;3(12):819-22.
1989: Cecilia Cheng-Mayer; C Weiss; D Seto; Jay A Levy
Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(21):8575-9.
1989: J R Edwards; P P Ulrich; P S Weintrub; M J Cowan; Jay A Levy; D W Wara; Girish Vyas
Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children.
The Journal of pediatrics 1989;115(2):200-3.
1989: J Homsy; M Meyer; M Tateno; S Clarkson; Jay A Levy
The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.
Science (New York, N.Y.) 1989;244(4910):1357-60.
1989: M Tateno; F Gonzalez-Scarano; Jay A Levy
Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(11):4287-90.
1989: Jay A Levy
Human immunodeficiency viruses and the pathogenesis of AIDS.
JAMA : the journal of the American Medical Association 1989;261(20):2997-3006.
1989: L A Evans; G Thomson-Honnebier; K Steimer; E Paoletti; M E Perkus; H Hollander; Jay A Levy
Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.
AIDS (London, England) 1989;3(5):273-6.
1989: W J Morrow; J Homsy; J W Eichberg; JF Krowka; L Z Pan; I Gaston; H Legg; N Lerche; J Thomas; Jay A Levy
Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment.
AIDS research and human retroviruses 1989;5(2):233-45.
1989: C M Walker; Jay A Levy
A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication.
Immunology 1989;66(4):628-30.
1989: C M Walker; D J Moody; Daniel P Stites; Jay A Levy
CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals.
Cellular immunology 1989;119(2):470-5.
1989: B A Castro; C M Walker; M Tateno; Cecilia Cheng-Mayer; R Heberling; J W Eichberg; Jay A Levy
Human immunodeficiency virus (HIV) from experimentally infected chimpanzees: isolation and characterization.
Journal of medical primatology 1989;18(3-4):337-42.
1989: B Michaelis; Jay A Levy
HIV replication can be blocked by recombinant human interferon beta.
AIDS (London, England) 1989;3(1):27-31.
1989: Jay A Levy
The human immunodeficiency viruses. Detection and pathogenesis.
Immunology series 1989;44():159-229.
1988: L A Evans; J Moreau; K Odehouri; D Seto; G Thomson-Honnebier; H Legg; A Barboza; Cecilia Cheng-Mayer; Jay A Levy
Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient.
Lancet 1988;2(8625):1389-91.
1988: M J Cowan; C Walker; K Culver; P S Weintrub; D W Wara; Jay A Levy
Maternally transmitted HIV infection in children.
AIDS (London, England) 1988;2(6):437-41.
1988: Jay A Levy
Can an AIDS vaccine be developed?
Transfusion medicine reviews 1988;2(4):264-71.
1988: C M Walker; K S Steimer; K L Rosenthal; Jay A Levy
Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual.
The Journal of clinical investigation 1988;82(6):2172-5.
1988: B A Castro; C D Weiss; L D Wiviott; Jay A Levy
Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.
Journal of clinical microbiology 1988;26(11):2371-6.
1988: M Tateno; Jay A Levy
MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV).
Virology 1988;167(1):299-301.
1988: J Sernatinger; A Hoffman; D Hardman; John P Kane; Jay A Levy
Neutralization of mouse xenotropic virus by lipoproteins involves binding to the virions.
The Journal of general virology 1988;69 ( Pt 10)():2657-61.
1988: L A Evans; J Moreau; K Odehouri; H Legg; A Barboza; Cecilia Cheng-Mayer; Jay A Levy
Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression.
Science (New York, N.Y.) 1988;240(4858):1522-5.
1988: Jay A Levy
Mysteries of HIV: challenges for therapy and prevention.
Nature 1988;333(6173):519-22.
1988: Jay A Levy
The human immunodeficiency virus and its pathogenesis.
Infectious disease clinics of North America 1988;2(2):285-97.
1988: Jay A Levy
The transmission of AIDS: the case of the infected cell.
JAMA : the journal of the American Medical Association 1988;259(20):3037-8.
1988: Cecilia Cheng-Mayer; J Homsy; L A Evans; Jay A Levy
Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(8):2815-9.
1988: Cecilia Cheng-Mayer; D Seto; M Tateno; Jay A Levy
Biologic features of HIV-1 that correlate with virulence in the host.
Science (New York, N.Y.) 1988;240(4848):80-2.
1988: L A Evans; J M Homsy; W J Morrow; I Gaston; C D Sooy; Jay A Levy
Human monoclonal antibody directed against gag gene products of the human immunodeficiency virus.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(3):941-3.
1988: J Homsy; G A Thomson-Honnebier; Cecilia Cheng-Mayer; Jay A Levy
Detection of human immunodeficiency virus (HIV) in serum and body fluids by sequential competition ELISA.
Journal of virological methods 1988;19(1):43-56.
1988: B A Castro; Cecilia Cheng-Mayer; L A Evans; Jay A Levy
HIV heterogeneity and viral pathogenesis.
AIDS (London, England) 1988;2 Suppl 1():S17-27.
1987: R B Stricker; T M McHugh; D J Moody; W J Morrow; Daniel P Stites; Marc Shuman; Jay A Levy
An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.
Nature 1987;327(6124):710-3.
1986: C M Walker; D J Moody; D P Stites; Jay A Levy
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
Science (New York, N.Y.) 1986;234(4783):1563-6.
1986: W J Morrow; J Homsy; C A Swanson; Y Ohashi; J Estes; Jay A Levy
Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice.
Immunology 1986;59(3):439-43.